Medical technology company Masimo has received marketing authorisation from the US Food and Drug Administration (FDA) for its SafetyNet Opioid System, an anti-opioid-overdosing device.

Approved for individuals aged 15 and older, the Masimo SafetyNet Opioid System is suitable for use in hospitals or at home to safeguard individuals taking prescribed opioid medications or using opioids illegitimately.

The SafetyNet Opioid system is a monitoring device designed to help identify life-threatening opioid overdose in individuals before it causes major harm or even death.

The device responds to potential opioid-induced respiratory depression (OIRD) in an individual caused by opioid use or overdose. The response takes the form of a series of escalating notifications to the device user as well as personal emergency contacts.

The notification action will ensure that the patient receives the appropriate treatment intervention, for example naloxone.

Masimo SafetyNet is a scalable and cloud-based patient management platform that enables clinical-grade spot-checking and continuous measurements. It also comprises digital care pathways and remote patient surveillance capabilities.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Last December, Masimo announced the limited market launch of an early warning indicator called Sepsis Index (Si).

Si uses aggregated data from Patient SafetyNet to provide early warning of possible sepsis or other causes of deterioration in a patient’s condition.

The Patient SafetyNet system integrates real-time physiological data from Masimo and third-party bedside monitoring equipment to create displays that are shown at central stations.